NOVEL-2NCT05568966
Collection of Blood Samples for New Diagnostic Devices 2
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 3 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 13 words Show 5 more changesShow less
- Trial completed
- Final enrollment: 16063 participants (planned 20000)
- Primary and study completion dates changed from estimate of Sep 20, 2026 to Sep 17, 2026
- Study description revised
- Site details revised at 7 of 7 sites
- Notable Phase changed: Not applicable → Not specified
- Primary and study completion pushed from Aug 20, 2026 to Sep 20, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Measurement of blood samples from patients with infection, cardiovascular disease, embolism or renal disease in a reference method and in a novel LumiraDx method.
Timeframe: Up to 5 years
Multiple measurements of blood samples from patients with infection, cardiovascular disease, embolism or renal disease in a novel LumiraDx method.
Timeframe: Up to 5 years
Arms and interventions
Blood Draw
Venous blood draw up to 24mL and/or 6 capillary fingersticks Interventions: Diagnostic Test: Venepuncture Diagnostic Test: Fingerstick
Diagnostic tests: Venous blood draw, Fingerstick
Sites
7 sites in 1 country